SCHEMBL28906243

SCHEMBL28906243

Cc1cc(-c2cnc3c(c2)c(Br)cn3C(=O)O)ccc1C1=CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.42
JAK1 P23458 1/20 0.42
BTK Q06187 1/20 0.42
GRM1 Q13255 7/20 0.41
GRM5 P41594 6/20 0.41
CYP11B2 P19099 1/20 0.41
PDK4 Q16654 1/20 0.41
WNT3A P56704 1/20 0.41
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
GABRA2 P47869 1/20 0.40
GABRB2 P47870 1/20 0.40
GABRA4 P48169 1/20 0.40
GABRE P78334 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21590284 0.96 JAK1 (0.43) HTR6JAK1BTKGRM1GRM5
SCHEMBL28503231 0.78 JAK1 (0.56) JAK1BTKGRM1GRM5CYP11B2
SCHEMBL28507487 0.75 MAP4K1 (0.51) JAK1GABRPGABRDGABRA1GABRB1
SCHEMBL28503257 0.75 CAMKK2 (0.42) BTKRET
SCHEMBL27025890 0.75 GRM1 (0.51) HTR6JAK1BTKGRM1GRM5
SCHEMBL28500725 0.74 MAP4K1 (0.42) RET
SCHEMBL20112166 0.74 PDK4 (0.58) HTR6JAK1GRM1GRM5PDK4
SCHEMBL16434777 0.73 GRM1 (0.56) HTR6JAK1GRM1GRM5PDK4
SCHEMBL31222903 0.73 NAMPT (0.54) HTR6GRM1GRM5CYP11B2PDK4
SCHEMBL23306173 0.72 NAMPT (0.55) BTKGRM1GRM5CYP11B2PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed